SHBG is one of those hormone markers that looks more decisive than it is. It can sharpen the meaning of a testosterone result, especially in midlife, but it cannot diagnose low testosterone, polycystic ovary syndrome, or metabolic disease by itself. The useful question is not whether the number is good. It is what the number changes about the clinical picture.
What SHBG actually carries
Sex hormone-binding globulin, or SHBG, is a protein made mainly by the liver. Its job is to bind sex hormones, especially testosterone and oestradiol, as they travel through the blood. MedlinePlus explains the practical point clearly: hormones bound to proteins are not available to tissues in the same way as unbound, or free, hormone. That is why SHBG often enters the conversation when symptoms and total testosterone do not quite agree.
This matters because total testosterone is a mixed measurement. It includes testosterone bound tightly to SHBG, testosterone weakly bound to albumin, and a small free fraction. Two people can have the same total testosterone but different SHBG, and therefore different estimates of free or bioavailable hormone. The lab result is not lying. It is incomplete without context.
Why total testosterone can mislead
The Endocrine Society’s guideline for testosterone therapy is deliberately conservative. It recommends diagnosing male hypogonadism only when symptoms are present and testosterone concentrations are unequivocally and consistently low, with repeat morning testing and accurate assays. Its 2018 guideline also emphasises free testosterone when indicated, rather than treating a single total testosterone value as a verdict.
SHBG is one reason for that caution. When SHBG is high, more testosterone may be bound, and free testosterone may be lower than the total number suggests. When SHBG is low, total testosterone may look unimpressive whilst the free fraction is less concerning. This is especially relevant in midlife, when weight change, thyroid function, medicines, liver health, and metabolic status can all move SHBG independently of the testes or ovaries.
That does not make free testosterone a perfect answer. Free testosterone assays vary, calculated estimates depend on the formula and inputs, and reference ranges are not interchangeable across laboratories. But when the clinical question is hormone availability rather than hormone inventory, SHBG can keep the conversation honest.
Low SHBG is often a metabolic clue
Low SHBG is sometimes discussed as if it simply means more active hormone. In women, that can matter when androgen symptoms are present. In men, it can complicate the interpretation of total testosterone. But low SHBG is also a metabolic signal. Mayo Clinic Laboratories lists SHBG as a possible adjunct in assessing insulin resistance and cardiovascular or type 2 diabetes risk, particularly in women.
The mechanism is still being worked through, but the pattern is not new. SHBG is made in the liver, and liver metabolism is closely tied to insulin resistance and fat accumulation. Research in midlife women has linked lower SHBG and higher liver fat with higher metabolic risk. The cautious interpretation is association, not destiny. A low SHBG result should not be used to diagnose diabetes or prescribe a hormone. It should make the rest of the metabolic picture harder to ignore: waist change, fasting glucose, HbA1c, triglycerides, blood pressure, and family history.
This is where SHBG is most useful outside a narrow hormone panel. It can connect two conversations that often happen separately: whether sex hormones are available to tissues, and whether the liver-metabolic environment is shifting in a way that deserves ordinary medical attention.
In women, SHBG belongs in the androgen picture
For women with acne, irregular cycles, scalp hair thinning, or hirsutism, SHBG can help explain why androgen effects appear stronger than total testosterone alone would predict. A lower SHBG level can leave a higher fraction of testosterone available to tissues. That is part of the reason SHBG appears in discussions of polycystic ovary syndrome, although PCOS is not diagnosed by SHBG alone.
The Endocrine Society’s hirsutism guideline focuses on testing for elevated androgen levels when the clinical score is abnormal, and it urges against broad testing where the likelihood of changing management is low. That guideline is a useful guardrail: symptoms, examination, menstrual history, and reliable androgen testing come before any single marker is elevated into a diagnosis. SHBG may refine the picture. It should not replace the picture.
This is also where women’s hormonal health has been poorly served by oversimplified testing narratives. The same SHBG value can mean different things in a woman using oestrogen-containing contraception, a woman with suspected PCOS, a woman in perimenopause, and a woman with thyroid disease. The biology overlaps. The clinical questions do not.
High SHBG can matter too
High SHBG gets less attention because the wellness market is more interested in low testosterone than in binding proteins. Yet high SHBG can lower the free fraction of testosterone even when total testosterone looks adequate. MedlinePlus notes that high SHBG may be related to liver disease, hyperthyroidism, certain eating disorders, oestrogen-containing medicines, and reduced sex-hormone production in males.
In practice, a high SHBG result should prompt a clinician to ask why it is high. Is the person taking oral oestrogen? Is thyroid function abnormal? Is there evidence of liver disease, undernutrition, or overtraining? The answer may have little to do with prescribing testosterone. Sometimes the binding protein is pointing away from the sex hormone and towards the system that changed it.
How to read the result without over-reading it
The cleanest use of SHBG is as an interpreter, not a scoreboard. It helps translate total testosterone into a more clinically relevant estimate, and it can flag metabolic or endocrine conditions that deserve ordinary medical work-up. It is not a target most people should try to raise or lower for its own sake.
That distinction matters because the internet tends to turn every biomarker into a lever. SHBG does move with weight, insulin resistance, thyroid status, liver health, sex-steroid exposure, and some medicines. But trying to manipulate SHBG directly is the wrong order of operations. The better sequence is to repeat unexpected results, check related hormones and metabolic markers, and ask whether the result fits the person in front of the clinician.
What this means in practice
- If total testosterone is borderline or does not match symptoms, ask whether SHBG and a reliable free testosterone estimate would clarify the result.
- Do not treat one low total testosterone result as a diagnosis. Repeat morning testing and clinical symptoms matter.
- If SHBG is low, look at metabolic markers such as HbA1c, fasting glucose, triglycerides, blood pressure, and waist change.
- In women with androgen symptoms, interpret SHBG alongside cycle history, total and free testosterone, and PCOS assessment rather than alone.
- If SHBG is high, review thyroid function, liver markers, oestrogen exposure, nutrition status, and relevant medicines.
- Avoid supplement or clinic claims that promise to optimise SHBG without first explaining why it changed.
What we don’t know
SHBG is associated with several important outcomes, but association is not the same as a treatment target. We still do not have clean evidence that changing SHBG itself improves symptoms, fertility, cardiometabolic risk, or long-term brain health independent of the underlying condition that moved it. We also need better standardisation of free testosterone measurement and clearer sex-specific thresholds for common midlife scenarios.
For now, SHBG is best treated as a useful translator. It can make a hormone panel more honest. It cannot make a diagnosis on its own.
Photo: Daniel Sone on Unsplash.